The average one-year price target for 10x Genomics (NasdaqGS:TXG) has been revised to $16.66 / share. This is an increase of 10.47% from the prior estimate of $15.08 dated November 7, 2025.
The price target is an average of many targets provided by analysts. The latest targets range from a low of $14.14 to a high of $19.95 / share. The average price target represents an increase of 4.85% from the latest reported closing price of $15.89 / share.
What is the Fund Sentiment?
There are 612 funds or institutions reporting positions in 10x Genomics. This is an increase of 73 owner(s) or 13.54% in the last quarter. Average portfolio weight of all funds dedicated to TXG is 0.07%, an increase of 5.98%. Total shares owned by institutions increased in the last three months by 4.79% to 148,968K shares. 
The put/call ratio of TXG is 0.27, indicating a bullish outlook.
What are Other Shareholders Doing?
ARK Investment Management holds 11,887K shares representing 10.21% ownership of the company. In its prior filing, the firm reported owning 13,892K shares , representing a decrease of 16.86%. The firm decreased its portfolio allocation in TXG by 29.87% over the last quarter.
ARKK - ARK Innovation ETF holds 10,118K shares representing 8.69% ownership of the company. In its prior filing, the firm reported owning 8,711K shares , representing an increase of 13.91%. The firm increased its portfolio allocation in TXG by 19.61% over the last quarter.
Millennium Management holds 5,438K shares representing 4.67% ownership of the company. In its prior filing, the firm reported owning 2,884K shares , representing an increase of 46.97%. The firm increased its portfolio allocation in TXG by 68.25% over the last quarter.
Sumitomo Mitsui Trust Holdings holds 5,381K shares representing 4.62% ownership of the company. In its prior filing, the firm reported owning 6,018K shares , representing a decrease of 11.83%. The firm decreased its portfolio allocation in TXG by 16.64% over the last quarter.
Nikko Asset Management Americas holds 5,377K shares representing 4.62% ownership of the company. In its prior filing, the firm reported owning 6,010K shares , representing a decrease of 11.77%. The firm decreased its portfolio allocation in TXG by 12.19% over the last quarter.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
